Canary Speech
Provo
About Canary Speech
Canary Speech is a technology company that uses AI-driven vocal digital biomarkers for conversational speech virtual health monitoring. The company's vocal biomarker technology enables voice to be used as a vital sign, ushering in a new era of machine learning in healthcare. Using only 20 seconds of conversational speech, its patented vocal biomarker technology models acoustic and linguistic features and returns analysis. Canary detects stress, mood, and energy levels before traditional clinical screening and visible symptoms, allowing clinicians, payers, and patients to address conditions more proactively. Canary's technology reduces readmissions, prevents hospitalizations, and provides a head start on wellness for patients and providers. Its current research simulates respiratory conditions, dementia and Alzheimer's disease, and clinical deterioration, with broad practical implications for simulating other disease states.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $22.3M
- Last round: Series Unknown (Jan 2025)
- Website: canaryspeech.com
- Phone: 801-376-2221
Industries & Categories
Artificial Intelligence (AI), Health Care, Information Technology, Machine Learning, Software
Social Profiles
Canonical: https://fsome.com/organization/canary-speech-5219 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.